top of page

EMPOWERING SNAKEBITE CARE

At VenomAid we are on a mission to enable best-in-class snakebite care and reduce the global burden of snakebites. By combining state-of-the-art antibody discovery, venomics insights, and affordable diagnostic technologies, we are developing the necessary tools to empower clinicians dealing with snakebite. With a heartfelt vision of a safer, more resilient world, we're tirelessly working to elevate snakebite care into the 21st century.

About Us

VenomAid is a medtech company at the forefront of revolutionizing snakebite care on a global scale by pioneering affordable diagnostics to reach previously neglected populations.

2023-12-13 VenomAid Lab Work-40.jpg

+++++++++++++++++++++

////////////////////////////

Snake_EKG_Final.png

Our resolve to bring about change was born from the urgency to bring snakebite care into the 21st century. Snakebite envenoming remains one of the world's most neglected tropical diseases, affecting millions annually and claiming over 100,000 lives.

By developing affordable technologies that can support clinical decision-making, we're committed to making snakebite care more accessible, efficient, and life-saving.

Recent
News

++++++++++++++++++++++++++++++

//////////////////////////////////////////////

positive result

blood sample

C

T

FLAGSHIP PROJECT

Bothrops Test

Rapid test for detection of
Bothrops atrox venom in clinical samples

Billede af Devin Kaselnak

Our Values

Since our inception in 2018, we've been on a relentless pursuit of change. We're more than a biotech and medtech company; we're agents of transformation in the realm of snakebite care. Our core values are etched in every endeavor:

Saving Limbs
& Lives

63.png

With simplicity, affordability, and reliability at the core of our diagnostic tests, we're rewriting the narrative of snakebite care, preserving limbs and lives.

Decentralising Snakebite Care

64.png

Empowerment lies at the heart of our mission. We equip medical personnel across the globe with tools to improve snakebite management.

Addressing the Neglect

65.png

Neglected problems demand solutions. We're advocates for change, driving awareness about neglected tropical diseases and steering snakebite care to the forefront of global discourse.

Meet the Team

Our team is an ensemble of scientists, entrepreneurs, and visionaries who have dedicated their careers to advancing the frontiers of snakebite envenoming research.

Jonas Arnold Jürgensen

Co-founder & CEO

Selma Belfakir

Industrial PhD student

Mads Laustsen

Board member

Cecilie Knudsen

Co-founder & CSO

Gert Tomczyk

Chairman of the board

Jens Bøegh

Advisor

Gina Ross

CTO

Andreas Laustsen-Kiel

Co-founder and board member

Henrik Harboe

Advisor

Pelle Knudsen

Research Scientist

Morten Munk

Board member

Jesper Kihl

Advisor

Snakebite in numbers

2.7M

ENVENOMINGS

100T

DEATHS

400T

DISFIGUREMENTS

+5B$

LOST IN GDP$

PUBLICATIONS

We strive to advance the boundaries of science but also address critical knowledge gaps in the realm of snakebite envenoming. 

MULTIPLEX LATERAL FLOW ASSAY DEVELOPMENT FOR SNAKE VENOM DETECTION IN BIOLOGICAL MATRICES

Scientific Reports

  • A novel monoclonal antibody-based lateral flow assay distinguishes Bothrops and Lachesis venoms within 15 minutes, offering a practical solution for point-of-care snakebite diagnosis in Brazil
     

  • The lateral flow assay allows rapid, naked-eye or smartphone assisted quantitative detection of Bothrops and Lachesis venoms in plasma and urine, with a limit of detection of 10-50 ng/mL in spiked plasma and urine, aand 50-500 ng/mL in spiked sera. 
     

  • This holds potential for improved diagnostic precision and patient outcomes in snakebite cases

Screenshot 2023-08-10 at 16.18.17.png

LIFE FOUNDATION PARTNERSHIP

Educational project together with LIFE foundation, titled FIGHT THE BITE

In Fight the Bite, students must investigate how antibodies can be used to both diagnose and treat snakebite envenomation.
 

  • Free course targeting htx and stx in the subject biology B in Denmark

  • Disposable materials for the course will be delivered at your high school

  • The duration of the course is three modules of 90 min.

KrakenOptimizedLargeFit_edited.png

AS FEATURED ON

3.png
1.png
2.png

PARTNERS & COLLABORATORS

Collaborating for
impact

Collaboration lies at the heart of our awareness endeavors. We forge partnerships with global health organizations, research institutions, manufacturers, and policymakers who share our commitment to alleviating the impact of snakebite envenoming. By aligning our efforts, we amplify our collective voice, advocate for increased funding for neglected tropical diseases, and influence policy decisions that catalyze change for snakebite victims globally.

6.png

GLOBAL ACCES DX

5.png

CENTER FOR ANTIBODY TECHNOLOGIES

7.png

FMT-HVD

bottom of page